| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 04/06/2011 | CN101396373B Cinobufacini extract and preparation method thereof |
| 04/06/2011 | CN101361951B Skin external preparation with anti-inflammation, itching-relieving and disinfection and sterilization function and preparation method thereof |
| 04/06/2011 | CN101357159B Shiji powder for preventing and treating taura syndrome virus and preparation method thereof |
| 04/06/2011 | CN101342277B Externally used antimicrobial spray for treating snore and preparation method thereof |
| 04/06/2011 | CN101337990B Humanized neutralizing antibody against rabies virus, method for preparing same and use |
| 04/06/2011 | CN101314032B Preparation technique for specified transfer factor oral preparation for typhoid fever, paratyphoid fever |
| 04/06/2011 | CN101306200B Preparation method of hepatitis b human immunoglobulin for intravenous injection |
| 04/06/2011 | CN101302252B Extrasin alphal (Tal) analogue, production process and medical use thereof |
| 04/06/2011 | CN101284030B Quality control methods of hairy holly root medicinal materials, extract or hairy holly root preparation |
| 04/06/2011 | CN101255166B Chiral separation of calanolide alcohols to give racemic calanolide A |
| 04/06/2011 | CN101249102B Medicament for curing lymph node |
| 04/06/2011 | CN101244041B Medicament for preventing and treating acute liver damnification and preparation thereof |
| 04/06/2011 | CN101229336B External used medicine for treating chronic eczema |
| 04/06/2011 | CN101220071B Stable 6-methoxy-2',3'-dideoxy guanine nucleoside, method for preparing the same and medicament composition containing the same |
| 04/06/2011 | CN101214375B Improved vaccines |
| 04/06/2011 | CN101195559B Process for producing resveratrol nano-crystallization and uses thereof |
| 04/06/2011 | CN101185757B Vaccine containing composite adjuvant and preparation method thereof |
| 04/06/2011 | CN101185638B Microemulsion preparation and preparation method thereof |
| 04/06/2011 | CN101182322B Method for preparing antiviral drug of Entecavir |
| 04/06/2011 | CN101167873B Technology for processing honey-prepared glutinous rehmannia |
| 04/06/2011 | CN101152571B Vaccine wine oil adjuvant containing momordica cochinchinensis soap and method for preparing the same |
| 04/06/2011 | CN101130491B Oligomer having fatty acid synthase restraining activity and uses thereof |
| 04/06/2011 | CN101062069B Whole coumarins extract from root of dahuriae angelica and the preparing method thereof |
| 04/06/2011 | CN101056623B Stabilized freeze-dried formulation for cephalosporin derivatives |
| 04/06/2011 | CN101052411B VLP-antigen conjugates and their uses as vaccines |
| 04/06/2011 | CN101035558B Multivalent canine vaccines against leptospira bratislava and other pathogens |
| 04/06/2011 | CN101020054B Inactivated vaccine for preventing and treating paramyxovirus disease of pigeon and its preparation |
| 04/05/2011 | US7919614 Synthetic polysaccharides, process for their preparation and pharmaceutical compositions containing them |
| 04/05/2011 | US7919524 Compounds, compositions and methods |
| 04/05/2011 | US7919513 Inhibitors of p38 |
| 04/05/2011 | US7919489 e.g. 4-({[(4-Chloro-2-methylphenyl)amino]carbonyl}amino)-1-(cyclopropylmethyl)-1H-imidazole-2-carboxylic acid; antiviral agents, especially against cytomegaloviruses and other Herpes viridae; side effect reduction; antibiotic resistance |
| 04/05/2011 | US7919479 Antiadhesive carbohydrates |
| 04/05/2011 | US7919470 Glycopeptide composition with improved antibiotic activity |
| 04/05/2011 | US7919309 Method for expression of small antiviral RNA molecules within a cell |
| 04/05/2011 | CA2572577C Synthesis of acyclic nucleoside derivatives |
| 04/05/2011 | CA2526538C Aqueous compositions for disinfection and/or sterilization |
| 04/05/2011 | CA2514681C Methods and compositions for inhibition of angiogenesis |
| 04/05/2011 | CA2496040C Derivatives of dioxan-2-alkyl carbamates, preparation method thereof and application of same in therapeutics |
| 04/05/2011 | CA2483028C Diffusion-controlled dosage form and method of fabrication including three dimensional printing |
| 04/05/2011 | CA2466170C Hexa-, hepta-, and octapeptides having antiangiogenic activity |
| 04/05/2011 | CA2408747C Heterocyclic inhibitors of glycogen synthase kinase gsk-3 |
| 04/05/2011 | CA2300854C Novel mutants of gram negative mucosal bacteria and application thereof in vaccines |
| 03/31/2011 | WO2011038313A2 Selective oxidation of c-h bonds of modified substrates by p450 monooxygenase |
| 03/31/2011 | WO2011038293A1 Cyclic peptide inhibitors of hepatitis c virus replication |
| 03/31/2011 | WO2011038283A1 Novel macrocyclic inhibitors of hepatitis c virus replication |
| 03/31/2011 | WO2011038157A2 Zinc-containing compositions for the treatment of diseases, illnesses and syndromes associated with exposure to pore forming toxins |
| 03/31/2011 | WO2011037411A2 Composition comprising s-allyl-l-cysteine as active ingredient for preventing or treating gastrointestinal disorders |
| 03/31/2011 | WO2011036895A1 Maleic acid salt and crystal thereof |
| 03/31/2011 | WO2011036883A1 Anti-influenza virus agent |
| 03/31/2011 | WO2011036560A2 Glycoconjugate compositions and methods for treatment of hiv |
| 03/31/2011 | WO2011036461A1 Fused imidazo [3, 2 - d] pyrazines as pi3 kinase inhibitors |
| 03/31/2011 | WO2011036304A1 Leaven-based mixture |
| 03/31/2011 | WO2011036159A2 Treatment and prevention of hiv infection |
| 03/31/2011 | WO2011036128A1 Heterocyclic antiviral compounds |
| 03/31/2011 | WO2011035734A1 Relinqing extract, preparative method and use thereof |
| 03/31/2011 | WO2011035534A1 Dihydropteridinone derivatives, preparation process and pharmaceutical use thereof |
| 03/31/2011 | WO2011035518A1 Pyrimidine derivatives and analogs, preparation method and use thereof |
| 03/31/2011 | WO2011035434A1 Gallium complex anti microbial compounds, compositions, uses and methods |
| 03/31/2011 | WO2011035422A1 Method of preparing plant-derived vlps |
| 03/31/2011 | WO2011015656A3 Composition for treating hbv infection |
| 03/31/2011 | WO2011012698A3 Phthalocyanine derivative consisting of a mixture of 4 isomers |
| 03/31/2011 | WO2010141133A3 Silk fibroin systems for antibiotic delivery |
| 03/31/2011 | WO2010134939A3 Mammalian genes involved in infection |
| 03/31/2011 | WO2010132852A3 Protease inhibitors |
| 03/31/2011 | WO2010117974A3 Hiv-resistant stem cells and uses thereof |
| 03/31/2011 | US20110077572 Medical Equipment and Products using Chlorine, Hydrogen Peroxide, and Anti-Viral, Anti-Bacterial, Anti-Fungal, Agents, usage Method Improvements Dread Disease Cures, Remissions, and Anti-Infective Treatment Measures, Disease Treatment and Prevention System |
| 03/31/2011 | US20110077402 Administration of dipeptidyl peptidase inhibitors |
| 03/31/2011 | US20110077289 Method of treating pneumoconiosis with oligodeoxynucleotides |
| 03/31/2011 | US20110077288 Pharmaceutical Compositions for Treatment of MicroRNA Related Diseases |
| 03/31/2011 | US20110077287 Pharmaceutical composition containing a stabilised mrna optimised for translation in its coding regions |
| 03/31/2011 | US20110077284 Dry powder compositions for rna influenza therapeutics |
| 03/31/2011 | US20110077280 Hepatitis C Virus Inhibitors |
| 03/31/2011 | US20110077278 Antifungal compositions and methods |
| 03/31/2011 | US20110077262 Novel spirochromanone carboxylic acids |
| 03/31/2011 | US20110077261 Prevention of hiv-infection |
| 03/31/2011 | US20110077252 Pyridyl derivatives, their preparation and use |
| 03/31/2011 | US20110077251 Novel 17 beta lupane derivatives |
| 03/31/2011 | US20110077249 1,2,4-triazolylaminoaryl (heteroaryl) sulfonamide derivatives |
| 03/31/2011 | US20110077242 Diaminopyrimidines as p2x3 and p2x2/3 antagonists |
| 03/31/2011 | US20110077228 Novel c-21-keto lupane derivatives preparation and use thereof |
| 03/31/2011 | US20110077227 Novel lupane derivatives |
| 03/31/2011 | US20110077225 4-Substituted Tetracyclines and Methods of Use Thereof |
| 03/31/2011 | US20110077221 Selective androgen receptor modulators, analogs and derivatives thereof and uses thereof |
| 03/31/2011 | US20110077198 Compositions and methods for inhibiting the activation of dsrna-dependent protein kinase and tumor growth inhibition |
| 03/31/2011 | US20110077194 Method for Treating or Preventing a Functional Vitamin B12 Deficiency in an Individual and to Medical Compositions for Use in Said Method |
| 03/31/2011 | US20110077193 Artemisinin Derivatives with Natural Amino Acids, Peptides, and Amino Sugars for the Treatment of Infection and Topical Condition in Mammals |
| 03/31/2011 | US20110077192 Novel Antibacterial Peptides |
| 03/31/2011 | US20110077190 Selective Caspase Inhibitors and Uses Thereof |
| 03/31/2011 | US20110077189 Composition for stimulating natural killer cell activity |
| 03/31/2011 | US20110076344 Use of a chemically-stabilized chlorite solution for inhibiting an antigen-specific immune response |
| 03/31/2011 | US20110076332 Dextran-chitosan based in-situ gelling hydrogels for biomedical applications |
| 03/31/2011 | US20110076326 Modified protein excipient for delayed-release tablet |
| 03/31/2011 | US20110076321 Self-adhesive polymer matrix containing sea algae extract |
| 03/31/2011 | US20110076315 Grafts and Stents Having Inorganic Bio-Compatible Calcium Salt |
| 03/31/2011 | US20110076314 Hydrophobic polysaccharides with silyl ether linkages having enhanced degradation and medical articles made therefrom |
| 03/31/2011 | US20110076313 Antimicrobial gas impregnated devices and methods |
| 03/31/2011 | US20110076306 Arabinogalactan for enhancing the adaptive immune response |
| 03/31/2011 | US20110076305 Extracellular matrix materials as vaccine adjuvants for diseases associated with infectious pathogens or toxins |
| 03/31/2011 | US20110076302 Plant-derived vaccines against respiratory syncytial virus |
| 03/31/2011 | US20110076300 Hybrid Polypeptides Including Meningococcal fHBP Sequences |